TR200102019T2 - The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections. - Google Patents
The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections.Info
- Publication number
- TR200102019T2 TR200102019T2 TR2001/02019T TR200102019T TR200102019T2 TR 200102019 T2 TR200102019 T2 TR 200102019T2 TR 2001/02019 T TR2001/02019 T TR 2001/02019T TR 200102019 T TR200102019 T TR 200102019T TR 200102019 T2 TR200102019 T2 TR 200102019T2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- infections
- hydroxylamic
- isoxazolidinones
- acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Söz konusu bulus formül (I)'e uygun asgari bir tane terkibi ihtiva eden ilaçlar ve bunlarin insanlarda ve hayvanlarda bakteriler, mantarlar ve parazitlerin sebep oldugu enfeksiyonlarin tedavisi ve bu enfeksiyonlardan korunmak amaci ile kullanilmalarini kapsamaktadir.(Formül Var)The present invention includes drugs containing at least one composition according to formula (I) and their use for the treatment and protection of infections caused by bacteria, fungi and parasites in humans and animals (Formula Var).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19900907 | 1999-01-13 | ||
DE19903666A DE19903666A1 (en) | 1999-01-13 | 1999-01-30 | Medicines containing 3-isoxazolidinones and hydroxylamic acids as an active ingredient and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102019T2 true TR200102019T2 (en) | 2002-04-22 |
Family
ID=26051290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02019T TR200102019T2 (en) | 1999-01-13 | 2000-01-12 | The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1143941A3 (en) |
JP (1) | JP2002534440A (en) |
CN (1) | CN1342078A (en) |
AU (1) | AU2436600A (en) |
BR (1) | BR0007491A (en) |
CA (1) | CA2360366A1 (en) |
CZ (1) | CZ20012380A3 (en) |
HU (1) | HUP0105412A2 (en) |
IL (1) | IL143795A0 (en) |
NO (1) | NO20013464L (en) |
PL (1) | PL350128A1 (en) |
SK (1) | SK9502001A3 (en) |
TR (1) | TR200102019T2 (en) |
WO (1) | WO2000041473A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
GB202209172D0 (en) * | 2022-06-22 | 2022-08-10 | Syngenta Crop Protection Ag | Improvements in or relating to organic compounds |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL45174A (en) * | 1973-08-10 | 1976-12-31 | Merck & Co Inc | Antibacterial compositions containing 3-fluoro-d-alanine type compound and n-substituted cycloserine compound |
US3911007A (en) * | 1974-08-08 | 1975-10-07 | Searle & Co | N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides |
FR2290442A1 (en) * | 1974-11-06 | 1976-06-04 | Aries Robert | Cycloserine-(hexahydro)rifamycin SV condensates - antibiotics, prepd from 3-formyl rifamycins and opt N-alkylated cycloserine |
EP0219923B1 (en) * | 1985-04-30 | 1992-09-02 | Takeda Chemical Industries, Ltd. | Antibiotic derivatives, their production and use |
GB8531838D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
JPS63119476A (en) * | 1986-11-05 | 1988-05-24 | Takeda Chem Ind Ltd | Isoxazolidone derivative |
JPS63119462A (en) * | 1986-11-05 | 1988-05-24 | Takeda Chem Ind Ltd | 5-membered-ring n-sulfo compound |
US5288896A (en) * | 1992-01-15 | 1994-02-22 | Warner-Lambert Company | 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor |
DE69412469T2 (en) * | 1993-03-16 | 1999-02-04 | British Biotech Pharm | HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS |
WO1995006031A1 (en) * | 1993-08-23 | 1995-03-02 | Immunex Corporation | Inhibitors of tnf-alpha secretion |
GB9401129D0 (en) * | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
WO1996013263A2 (en) * | 1994-11-01 | 1996-05-09 | Research Corporation Technologies, Inc. | Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis |
US5919790A (en) * | 1996-10-11 | 1999-07-06 | Warner-Lambert Company | Hydroxamate inhibitors of interleukin-1β converting enzyme |
US6251913B1 (en) * | 1997-03-28 | 2001-06-26 | Zeneca Limited | Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
AUPO721997A0 (en) * | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
-
2000
- 2000-01-12 IL IL14379500A patent/IL143795A0/en unknown
- 2000-01-12 TR TR2001/02019T patent/TR200102019T2/en unknown
- 2000-01-12 AU AU24366/00A patent/AU2436600A/en not_active Abandoned
- 2000-01-12 WO PCT/EP2000/000165 patent/WO2000041473A2/en not_active Application Discontinuation
- 2000-01-12 PL PL00350128A patent/PL350128A1/en not_active Application Discontinuation
- 2000-01-12 CN CN00802779A patent/CN1342078A/en active Pending
- 2000-01-12 EP EP00902582A patent/EP1143941A3/en not_active Withdrawn
- 2000-01-12 SK SK950-2001A patent/SK9502001A3/en unknown
- 2000-01-12 BR BR0007491-8A patent/BR0007491A/en not_active Application Discontinuation
- 2000-01-12 CZ CZ20012380A patent/CZ20012380A3/en unknown
- 2000-01-12 HU HU0105412A patent/HUP0105412A2/en unknown
- 2000-01-12 JP JP2000593097A patent/JP2002534440A/en active Pending
- 2000-01-12 CA CA002360366A patent/CA2360366A1/en not_active Abandoned
-
2001
- 2001-07-12 NO NO20013464A patent/NO20013464L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SK9502001A3 (en) | 2002-05-09 |
BR0007491A (en) | 2001-11-20 |
EP1143941A3 (en) | 2002-02-06 |
WO2000041473A3 (en) | 2001-11-29 |
IL143795A0 (en) | 2002-04-21 |
HUP0105412A2 (en) | 2002-05-29 |
CN1342078A (en) | 2002-03-27 |
CA2360366A1 (en) | 2000-07-20 |
NO20013464L (en) | 2001-09-12 |
PL350128A1 (en) | 2002-11-04 |
AU2436600A (en) | 2000-08-01 |
EP1143941A2 (en) | 2001-10-17 |
NO20013464D0 (en) | 2001-07-12 |
CZ20012380A3 (en) | 2002-01-16 |
WO2000041473A2 (en) | 2000-07-20 |
JP2002534440A (en) | 2002-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE303993T1 (en) | 4-HYDROXYCHINOLINE-3-CARBOXAMIDE AND HYDRAZIDE AS ANTIVIRAL ACTIVES | |
PT1073470E (en) | Pharmaceutical compositions containing active compounds capable of improving the absorption of active ingredients | |
PT750618E (en) | OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
ES2172585T3 (en) | DERIVED FROM BENZOIMIDAZOL. | |
TR200101499T1 (en) | Azepinoindole derivatives, their preparation and uses. | |
YU48701A (en) | Phenylphenanthridines with pde-iv inhibiting activity | |
ES2153975T3 (en) | DERIVATIVES OF PIRIMIDONA WITH ANTIFUNGIC ACTIVITY. | |
TR200101124T2 (en) | N- (2-aryl-propionyl) -sulphonamides and pharmaceutical preparations containing them. | |
TR200200883T2 (en) | 2-substituted 1,1-biphenyl-2-carbonamides, manufacturing methods, use as drugs | |
AR014554A1 (en) | POLYPEPTIDE COMPOUNDS, USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS, PROCEDURE TO PREPARE THEM, COMPOSITIONS AND MEDICINES THAT INCLUDE AND THE USE OF SUCH COMPOUNDS AND METHOD FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIONS | |
TR200101649T2 (en) | Piperazine derivatives. | |
BR0001201A (en) | (Poly) thiaalkinoic compound, cosmetic composition, use of a cosmetic composition, use of a compound and pharmaceutical composition | |
TR200101979T2 (en) | 5HT1 antagonists for antidepression treatment. | |
TR200101841T2 (en) | The use of bisphosphonates to prevent infections and treat infections | |
DE50011645D1 (en) | SPHINGOMYELINASE INHIBITORS AS ACTIVE AGENTS WITH ANTIAPOPTOTIC AND ANTISEPTIC EFFECT | |
TR200101832T2 (en) | Organophosphorus compositions and their use. | |
TR200102019T2 (en) | The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections. | |
FR2768145B1 (en) | NOVEL COMPOUNDS DERIVED FROM DI- OR TRI-ACETIC ALKYLENE DIAMINE ACID, PROCESS FOR THEIR PREPARATION, THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS COMPRISING THE SAME | |
TR200003451T2 (en) | Pyrimidine-Aminomethyl-Pyridine Derivatives, Their Preparation and Their Use in the Control of Helicobacter Bacteria | |
DE59403472D1 (en) | MICROBICIDAL AGENTS | |
TR199901454T2 (en) | Uses of aminoisothiazoles as germicides. | |
BR9808210A (en) | Befenyloxazolines dissubstituted | |
TR200103212T2 (en) | Ethers used as a fungicide | |
ATE241640T1 (en) | FUSIDIC ACID DERIVATIVES | |
ES2069803T3 (en) | USE OF PIRIDINARY SALTS FOR THE PROTECTION OF PLANTS AGAINST ATTACK BY MICROORGANISMS. |